Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Katz

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
JAMA Dermatology|January 15, 2016
Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for InclusionKenneth A Katz
Archives of Dermatology|December 21, 2005
AMEVIVE's advertisements: problematic?Kenneth A Katz
Dermatology Online Journal|November 5, 2003
Frontal linear scleroderma (en coup de sabre)Kenneth A Katz
The Lancet. Infectious Diseases|April 25, 2014
Imiquimod is not an effective drug for molluscum contagiosumKenneth A Katz
JAMA Dermatology|August 8, 2019
A Viewpoint on Viewpoints-Tips for Authors From JAMA DermatologyKenneth A Katz
Archives of Dermatology|May 19, 2010
Dory flop sign of syphilisKenneth A Katz
Archives of Dermatology|March 19, 2008
Time to nip "seeding trials" in the budKenneth A Katz
JAMA Dermatology|June 9, 2016
Syphilis Screening in the 21st Century: New Recommendations for an Old DiseaseKenneth A Katz
The British Journal of Dermatology|April 26, 2006
'Biologics': a clinically meaningless termKenneth A Katz
JAMA|November 26, 2009
Participating in biomedical researchKenneth A Katz
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
JAMA Dermatology|January 15, 2016
Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for InclusionKenneth A Katz
Archives of Dermatology|December 21, 2005
AMEVIVE's advertisements: problematic?Kenneth A Katz
Dermatology Online Journal|November 5, 2003
Frontal linear scleroderma (en coup de sabre)Kenneth A Katz
The Lancet. Infectious Diseases|April 25, 2014
Imiquimod is not an effective drug for molluscum contagiosumKenneth A Katz
JAMA Dermatology|August 8, 2019
A Viewpoint on Viewpoints-Tips for Authors From JAMA DermatologyKenneth A Katz
Archives of Dermatology|May 19, 2010
Dory flop sign of syphilisKenneth A Katz
Archives of Dermatology|March 19, 2008
Time to nip "seeding trials" in the budKenneth A Katz
JAMA Dermatology|June 9, 2016
Syphilis Screening in the 21st Century: New Recommendations for an Old DiseaseKenneth A Katz
The British Journal of Dermatology|April 26, 2006
'Biologics': a clinically meaningless termKenneth A Katz
JAMA|November 26, 2009
Participating in biomedical researchKenneth A Katz
Pageof 10